AccuGenomics’ highly versatile SNAQ™-SEQ spike-in control technology is available for license and can be applied to a wide range of multiplexed molecular diagnostic modalities. Ideal applications include qPCR, digital PCR for oncology and infectious disease testing, Next Generation Sequencing, RNA expression, Whole Exome Sequencing and more. Designing assays with a spike-in control strategy from the outset will yield better performing assays with faster market adoption and more satisfied customer base. SNAQ-SEQ and SNAQ-PCR is a cost-effective tool to improve your development and commercial roll out. AccuGenomics is happy to provide consultatory support services on how to integrate SNAQ-SEQ spike in control technology for your next molecular assay.